Chromium D-Pantothenate

Chromium D-Pantothenate combines chromium with D-pantothenate, the biologically active form of vitamin B5. This compound theoretically supports glucose metabolism through chromium's insulin-enhancing properties and pantothenate's role in coenzyme A synthesis.

Origin & History

Chromium D-Pantothenate is a salt combining the mineral chromium with D-pantothenate, the biologically active anion of D-pantothenic acid (vitamin B5). The D-pantothenate component is synthetically derived from pantoic acid and β-alanine, with no specific natural organism or plant source indicated. It appears as a pharmaceutical secondary standard, often produced chemically for nutraceutical use.

Historical & Cultural Context

No historical or traditional medicine uses are documented for Chromium D-Pantothenate in the search results. Pantothenic acid is described as a modern nutraceutical without referenced traditional context.

Health Benefits

• No specific health benefits documented - No human clinical trials or RCTs available for Chromium D-Pantothenate in the research dossier
• Related vitamin B5 activity suggested - D-pantothenate is the biologically active form of pantothenic acid, though specific benefits not studied
• Investigational nutraceutical status - Pantothenic acid salts have Phase 2 investigational status per ChEMBL, but no outcome data provided
• Potential cosmetic applications - Used in hair/skin products as pantothenic acid salts, suggesting topical applications
• No evidence-based claims possible - Search results provide no PMIDs, study details, or clinical outcomes for this specific compound

How It Works

Chromium D-Pantothenate theoretically works through dual pathways: chromium enhances insulin sensitivity by activating insulin receptors and improving glucose transporter GLUT4 function, while D-pantothenate serves as a precursor to coenzyme A, essential for fatty acid oxidation and carbohydrate metabolism. The pantothenate component may also improve chromium bioavailability and cellular uptake compared to inorganic chromium forms.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Chromium D-Pantothenate were found in the research. While pantothenic acid and its salts like calcium D-pantothenate have investigational status (Phase 2 per ChEMBL), no PubMed PMIDs or study details regarding design, sample size, or outcomes are available.

Clinical Summary

No specific clinical trials have evaluated Chromium D-Pantothenate as a distinct compound. Research on chromium supplementation generally shows modest effects on glucose metabolism, with studies using 200-1000 mcg daily showing mixed results for glycemic control. Pantothenic acid research focuses primarily on deficiency states rather than supplementation benefits. The lack of dedicated research on this specific chromium-pantothenate complex limits evidence-based conclusions about its efficacy.

Nutritional Profile

Chromium D-Pantothenate is a dual-function mineral-vitamin complex that serves as a coordinated salt delivering both trivalent chromium (Cr³⁺) and D-pantothenic acid (vitamin B5). **Mineral component:** Provides elemental chromium, typically yielding approximately 10–14% chromium by molecular weight depending on the stoichiometry of the salt (commonly formulated as Cr(C₉H₁₆NO₅)₂ or Cr(C₉H₁₆NO₅)₃). Chromium is an essential trace mineral involved in insulin signaling and glucose metabolism, with adequate intake (AI) set at 25–35 µg/day for adults. **Vitamin component:** D-pantothenate is the biologically active enantiomer of pantothenic acid (vitamin B5), a precursor to coenzyme A (CoA) and acyl carrier protein (ACP), critical for fatty acid synthesis, energy metabolism via the TCA cycle, and acetylation reactions. The AI for pantothenic acid is 5 mg/day for adults. **Bioactive compounds:** The complex provides no fiber, protein, or fat; it is purely a mineral-vitamin salt. No significant secondary bioactive compounds are present. **Bioavailability notes:** Trivalent chromium salts generally have low oral bioavailability (0.4–2.5%), though organic chromium complexes (such as pantothenate, picolinate, or nicotinate forms) are considered to have modestly improved absorption compared to inorganic salts like chromium chloride. D-pantothenic acid from the pantothenate moiety is well absorbed in the small intestine via sodium-dependent multivitamin transporter (SMVT), with bioavailability estimated at ~40–60% at physiological doses. The chelated/coordinated form may offer improved stability in the GI tract compared to separate administration of chromium and pantothenic acid. No standardized concentrations exist for supplement formulations; typical dosing in commercial products ranges from 200–1000 µg of elemental chromium per serving, with corresponding pantothenate delivery varying by stoichiometric ratio.

Preparation & Dosage

No clinically studied dosage ranges are available for Chromium D-Pantothenate in any form (extract, powder, or standardized). Related calcium pantothenate has FCC purity criteria (≥97.0% to ≤103.0%), but no dosing from studies is specified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research to determine synergistic ingredients

Safety & Interactions

Safety data specific to Chromium D-Pantothenate is unavailable, requiring reliance on individual component profiles. Chromium supplementation at typical doses (200-400 mcg daily) is generally well-tolerated but may enhance insulin effects, requiring blood glucose monitoring in diabetics. Pantothenic acid is considered very safe with no established upper limit, though high doses may cause mild gastrointestinal upset. No specific drug interactions are documented for this combination, but chromium may theoretically enhance hypoglycemic medications.